Although it remains uncertain whether diabetes management reduces dementia risk, a recent study that combined RCT data and Danish nationwide registry data suggested a beneficial effect of glucagon-like peptide-1 (GLP-1) on dementia risk in patients with type 2 diabetes.32 This evidence concerns the gene GLP1R and type 2 diabetes mellitus.